NYSE American - Nasdaq Real Time Price USD

Cybin Inc. (CYBN)

Compare
8.89
-0.67
(-7.01%)
At close: January 10 at 4:00:00 PM EST
9.05
+0.16
+(1.80%)
After hours: January 10 at 7:47:14 PM EST
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
--
--
--
--
864.00
Cost of Revenue
--
--
--
--
664.00
Gross Profit
--
--
--
--
200.00
Operating Expense
130,790.00
78,836.00
51,518.00
63,838.00
30,724.00
Operating Income
-130,790.00
-78,836.00
-51,518.00
-63,838.00
-30,524.00
Net Non Operating Interest Income Expense
5,702.00
619.00
603.00
241.00
50.00
Other Income Expense
1,396.00
137.00
3,425.00
-4,034.00
-1,746.00
Pretax Income
-123,692.00
-78,080.00
-47,490.00
-67,631.00
-32,220.00
Net Income Common Stockholders
-123,692.00
-78,080.00
-47,490.00
-67,631.00
-32,220.00
Diluted NI Available to Com Stockholders
-123,692.00
-78,080.00
-47,490.00
-67,631.00
-32,220.00
Basic EPS
-8.55
-9.50
-9.88
-15.20
-12.16
Diluted EPS
-8.55
-9.50
-9.88
-15.20
-12.16
Basic Average Shares
15,397.43
8,297.37
4,879.70
4,402.30
2,631.86
Diluted Average Shares
19,992.86
8,297.37
4,879.70
4,402.30
2,631.86
Total Expenses
130,790.00
78,836.00
51,518.00
63,838.00
31,388.00
Net Income from Continuing & Discontinued Operation
-123,692.00
-78,080.00
-47,490.00
-67,631.00
-32,220.00
Normalized Income
-125,088.00
-78,217.00
-50,915.00
-63,597.00
-30,474.00
Interest Income
5,702.00
619.00
603.00
241.00
60.00
Interest Expense
--
--
--
--
10.00
Net Interest Income
5,702.00
619.00
603.00
241.00
50.00
EBIT
-130,790.00
-78,836.00
-51,518.00
-63,838.00
-32,210.00
EBITDA
-130,225.00
-78,412.00
-51,267.00
-63,670.00
-32,161.00
Reconciled Cost of Revenue
--
--
--
--
664.00
Reconciled Depreciation
565.00
424.00
251.00
168.00
49.00
Net Income from Continuing Operation Net Minority Interest
-123,692.00
-78,080.00
-47,490.00
-67,631.00
-32,220.00
Total Unusual Items Excluding Goodwill
1,396.00
137.00
3,425.00
-4,034.00
-1,746.00
Total Unusual Items
1,396.00
137.00
3,425.00
-4,034.00
-1,746.00
Normalized EBITDA
-131,621.00
-78,549.00
-54,692.00
-59,636.00
-30,415.00
3/31/2021 - 9/13/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ATAI Atai Life Sciences N.V.
1.5000
-7.41%
 
MNMD Mind Medicine (MindMed) Inc.
6.93
-1.98%
 
GHRS GH Research PLC
8.57
-4.57%
 
ATRA Atara Biotherapeutics, Inc.
15.55
-5.93%
 
MURA Mural Oncology plc
3.8900
+6.58%
 
MDMA.CN Pharmala Biotech Holdings Inc.
0.3100
+16.98%
 
CMND Clearmind Medicine Inc.
1.5300
+6.25%
 
PALI Palisade Bio, Inc.
1.9100
-4.98%
 
SAGE Sage Therapeutics, Inc.
5.55
-5.13%
 
DRUG Bright Minds Biosciences Inc.
38.89
-5.24%